The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope

Human Gene Therapy

Volumn 13, Issue 10, 2002, Pages 1167-1178

  Olive, Melanie ^a,b   Eisenlohr, Laurence ^c,d   Flomenberg, Neal ^b,c,d   Hsu, Susan ^e   Flomenberg, Phyllis ^a,b,d  

^a Center for Human Virology   (United States)

^b Department of Medicine ^*  (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e AMERICAN RED CROSS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ASPARTYLGLUTAMYLPROLYLTHREONYLLEUCYLLEUCYLTYROSYLVALYLLEUCYLPHENYLALANYLGLU TAMYLVALYLPHENYLALANYLASPARTYLVALINE; CAPSID PROTEIN; EPITOPE; GAMMA INTERFERON; HLA A2 ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; PEPTIDE DERIVATIVE; PROTEIN HEXON; UNCLASSIFIED DRUG; CD4 ANTIGEN; HEXON CAPSID PROTEIN, ADENOVIRUS; VIRUS ANTIGEN;

ADULT; AGED; ALLELE; AMINO ACID SEQUENCE; ARTICLE; ASSAY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; IMMUNOPHENOTYPING; MEMORY CELL; MONONUCLEAR CELL; NORMAL HUMAN; QUANTITATIVE ANALYSIS; SEQUENCE ANALYSIS; SEROTYPE; T LYMPHOCYTE; ADENOVIRUS; ADOLESCENT; CD4+ T LYMPHOCYTE; CELL LINE; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE;

ADENOVIRIDAE; ADOLESCENT; ADULT; AGED; AMINO ACID SEQUENCE; ANTIGENS, CD4; ANTIGENS, VIRAL; CAPSID PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CONSERVED SEQUENCE; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HLA-A2 ANTIGEN; HLA-DR ANTIGENS; HUMAN; INTERFERON TYPE II; MIDDLE AGE; MOLECULAR SEQUENCE DATA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; HUMANS; MIDDLE AGED;

ADENOVIRIDAE; HUMAN ADENOVIRUS;

EID: 0036019189     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303402320138952     Document Type: Article

References (48)

1. Gene therapy for lung disease: Hype or hope?
2. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2
3. Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells
4. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: Identification of a universal T cell epitope in thePlasmodium falciparum circumsporozoite protein
5. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide
6. Immune responses to adenovirus and adeno-associated virus in humans
7. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression
8. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection
9. HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles
10. MHC II-restricted CD4+ cytotoxic T lymphocytes specific for herpes simplex virus-1: Implications for the development of herpetic stromal keratitis in mice
11. Characterization of human proliferative T cell responses to adenovirus
12. Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon
13. The amino terminus of the adenovirus fiber protein encodes the nuclear localization signal
14. Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors
15. Human cytotoxic T-lymphocyte repertoire to influenza A viruses
16. Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver
17. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: Implications for gene therapy
18. Rapid effector function in CD8+ memory T cells
19. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis
20. A recombinant vaccinia virus based ELISPOT assay detects high frequencies of Pol-specific CD8 T cells in HIV-1-positive individuals
21. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity
22. Detection and quantification of CD4(+) T cells with specificity for a new major histocompatibility complex class II-restricted influenza A virus matrix protein epitope in peripheral blood of influenza patients
23. Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotype
24. The three-dimensional structure of peptide-MHC complexes
25. Immune response to recombinant adenovirus in humans: Capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes
26. Quantitative analysis of adenovirus-specific CD4+ T cell responses from healthy adults
27. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains
28. Specificity of the mouse cytotoxic T lymphocyte response to adenovirus 5. E1A is immunodominant in H-2b, but not in H-2d or H-2k mice
29. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis
30. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
31. Type-specific epitope locations revealed by X-ray crystallographic study of adenovirus type 5 hexon
32. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
33. Worldwide epidemiology of human adenovirus infections
34. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors
35. Adenoviridae: The viruses and their replication
36. Extensive cross-reactivity of adenovirus-specific cytotoxic T cells
37. Several common HLA-DR types share largely overlapping peptide binding repertoires
38. Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein
39. The 'adenobody' approach to viral targeting: Specific and enhanced adenoviral gene delivery
40. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types
41. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins
42. Methods of gene delivery
43. Role of alveolar macrophages in rapid elimination of adenovirus vectors administered to the epithelial surface of the respiratory tract
44. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation
45. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
46. Role of viral antigens in destructive cellular immune responses to adenovirus vector-transduced cells in mouse lungs
47. Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells
48. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages